/

Empresas

RE

No verificado

REVEAL GENOMICS, S.L.

Sobre qué escribimos

BiotecnologíaIndustriaIr de comprasOncologíaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

04/11/2025

Industria

Técnica

Farmacéutica

Oncología

Tercera edad

Sanidad

Ciencia

Biotecnología

Software

Ir de compras

Salud

Nature Communications Study Supports HER2DX as a Genomic Tool for Tailored Therapy in Older Individuals With HER2+ Breast Cancer

Fuente

REVEAL GENOMICS, S.L.

Editor

1.00

0

27/05/2025

ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients

Fuente

REVEAL GENOMICS, S.L.

Editor

1.00

0

10/03/2025

Industria

Oncología

Salud

Sanidad

Biotecnología

Medicina - Varios

Groundbreaking Study Confirms Clinical Decision Impact of HER2DX® Genomic Assay in Early-Stage HER2-Positive Breast Cancer

Fuente

REVEAL GENOMICS, S.L.

Editor

1.00

0

13/01/2025

REVEAL GENOMICS® Links Immune Tumor Response to Longevity in Breast Cancer Survivors

Fuente

REVEAL GENOMICS, S.L.

Editor

1.00

0

Seguidores

0

Compatibilidad

0